Prenumeration
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
Oslo, Norway, 22 May 2026 – Circio Holding ASA (OSE: CRNA) (“Circio” or the “Company”), a biotechnology company developing novel circular RNA expression technology for gene and cell therapy, announces that the exercise price for the 67,680,945 warrants issued on ISIN NO0013711523 in connection with the rights issue and related private placement (Nw.: frittstående tegningsretter) (the “Warrants”) has been set.
The exercise price per Warrant is NOK 8.2508 (the "Exercise Price").
The Exercise Price represents a 20% discount to the volume-weighted average trading price ("VWAP") of the shares of Circio in the period from 8 May to 22 May 2026. The VWAP of the Company's shares in the period was NOK 10.3135.
KEY TERMS AND DATES:
- Warrant trading: The Warrants are listed and tradable on the Oslo Stock Exchange under the ticker code "CRNAS" with ISIN NO0013711523
- Warrant trading period: The Warrants are tradable up to and including 3 June 2026
- Warrant exercise period: 26 May - 9 June 2026
- Unexercised Warrants: Warrants not exercised by the end of the exercise period will lapse without any compensation to the holder
- Notification of allocation: 10 June 2026
- Warrant payment date: 12 June 2026
- Tradability and delivery of new shares: On or about 19 June 2026
MAIN ALTERNATIVES FOR WARRANT HOLDERS:
- Exercise currently held Warrants during the exercise period, pay the exercise price and receive new shares in Circio.
- Buy additional Warrants on the Oslo Stock Exchange. Subsequently exercise all held Warrants during the exercise period, pay the exercise price and receive new shares in Circio.
- Sell a portion of currently held Warrants during the trading period. Subsequently exercise the remaining Warrants held during the exercise period, pay the exercise price and receive shares in Circio.
- Sell all currently held Warrants during the trading period on the Oslo Stock Exchange.
- Do nothing. Warrants not exercised by 9 June 2026 will lapse without any compensation to the holder.
INFORMATION RELATED TO FINANCING OF WARRANTS:
With regard to the first 3 alternatives above (involving the exercise of Warrants), exercising Warrants means buying new shares in Circio at the Exercise Price (NOK 8.2508), and the aggregate exercise price must be settled with cash on the Warrant payment date (12 June 2026). It is imperative that investors planning to exercise Warrants secure sufficient financing to cover the aggregate exercise price ahead of the Warrant payment date.
HOW TO EXERCISE WARRANTS:
During the exercise period (26 May – 9 June 2026), Warrants can be exercised (i) by following the instructions on the websites of Pareto Securities (www.paretosec.com/transactions) and Circio, or (ii) manually by contacting Pareto Securities directly (please see contact details below).
Q&A RELATED TO THE WARRANTS:
Please visit the websites of Pareto Securities: https://paretosec.no/investeringer/emisjoner/warranter-circio-holding
FURTHER INFORMATION ABOUT THE WARRANTS:
The grant or purchase of Warrants by persons resident in, or who are citizens of countries other than Norway or Sweden, may be affected by the laws of the relevant jurisdiction. For a further description of such restrictions, reference is made to Section 11 "Selling and Transfer Restrictions" in the securities note dated 13 January 2026 (the "Securities Note", and together with a registration document dated 1 October 2025, and a registration document supplement and summary dated 13 January 2026, comprise the "Prospectus").
For more information about the Warrants, please refer to the Prospectus. The Prospectus is available on the Company's website: https://www.circio.com/en/prospectus-for-the-rights-issue-2026/